Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 6
2021 11
2022 11
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives.
Sa-Ngiamsuntorn K, Suksatu A, Pewkliang Y, Thongsri P, Kanjanasirirat P, Manopwisedjaroen S, Charoensutthivarakul S, Wongtrakoongate P, Pitiporn S, Chaopreecha J, Kongsomros S, Jearawuttanakul K, Wannalo W, Khemawoot P, Chutipongtanate S, Borwornpinyo S, Thitithanyanont A, Hongeng S. Sa-Ngiamsuntorn K, et al. Among authors: manopwisedjaroen s. J Nat Prod. 2021 Apr 23;84(4):1261-1270. doi: 10.1021/acs.jnatprod.0c01324. Epub 2021 Apr 12. J Nat Prod. 2021. PMID: 33844528 Free PMC article.
Virus MIP-composites for SARS-CoV-2 detection in the aquatic environment.
Sukjee W, Thitithanyanont A, Manopwisedjaroen S, Seetaha S, Thepparit C, Sangma C. Sukjee W, et al. Among authors: manopwisedjaroen s. Mater Lett. 2022 May 15;315:131973. doi: 10.1016/j.matlet.2022.131973. Epub 2022 Feb 26. Mater Lett. 2022. PMID: 35250128 Free PMC article.
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations.
Jitobaom K, Boonarkart C, Manopwisedjaroen S, Punyadee N, Borwornpinyo S, Thitithanyanont A, Avirutnan P, Auewarakul P. Jitobaom K, et al. Among authors: manopwisedjaroen s. BMC Pharmacol Toxicol. 2022 Jun 18;23(1):41. doi: 10.1186/s40360-022-00580-8. BMC Pharmacol Toxicol. 2022. PMID: 35717393 Free PMC article.
CoronaVac induces lower neutralising activity against variants of concern than natural infection.
Vacharathit V, Aiewsakun P, Manopwisedjaroen S, Srisaowakarn C, Laopanupong T, Ludowyke N, Phuphuakrat A, Setthaudom C, Ekronarongchai S, Srichatrapimuk S, Wongsirisin P, Sangrajrang S, Imsuwansri T, Kirdlarp S, Nualkaew S, Sensorn I, Sawaengdee W, Wichukchinda N, Sungkanuparph S, Chantratita W, Kunakorn M, Rojanamatin J, Hongeng S, Thitithanyanont A. Vacharathit V, et al. Among authors: manopwisedjaroen s. Lancet Infect Dis. 2021 Oct;21(10):1352-1354. doi: 10.1016/S1473-3099(21)00568-5. Epub 2021 Aug 26. Lancet Infect Dis. 2021. PMID: 34454652 Free PMC article. No abstract available.
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity.
Shanmugaraj B, Khorattanakulchai N, Panapitakkul C, Malla A, Im-Erbsin R, Inthawong M, Sunyakumthorn P, Hunsawong T, Klungthong C, Reed MC, Kemthong T, Suttisan N, Malaivijitnond S, Srimangkornkaew P, Klinkhamhom A, Manopwisedjaroen S, Thitithanyanont A, Taychakhoonavudh S, Phoolcharoen W. Shanmugaraj B, et al. Among authors: manopwisedjaroen s. Vaccine. 2022 Jul 30;40(32):4440-4452. doi: 10.1016/j.vaccine.2022.05.087. Epub 2022 Jun 6. Vaccine. 2022. PMID: 35697573 Free PMC article.
Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir.
Kongsomros S, Suksatu A, Kanjanasirirat P, Manopwisedjaroen S, Prasongtanakij S, Jearawuttanakul K, Borwornpinyo S, Hongeng S, Thitithanyanont A, Chutipongtanate S. Kongsomros S, et al. Among authors: manopwisedjaroen s. Biomedicines. 2021 Sep 16;9(9):1230. doi: 10.3390/biomedicines9091230. Biomedicines. 2021. PMID: 34572416 Free PMC article.
Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2.
Seephetdee C, Buasri N, Bhukhai K, Srisanga K, Manopwisedjaroen S, Lertjintanakit S, Phueakphud N, Pakiranay C, Kangwanrangsan N, Srichatrapimuk S, Kirdlarp S, Sungkanuparph S, Chutipongtanate S, Thitithanyanont A, Hongeng S, Wongtrakoongate P. Seephetdee C, et al. Among authors: manopwisedjaroen s. Vaccines (Basel). 2021 May 12;9(5):498. doi: 10.3390/vaccines9050498. Vaccines (Basel). 2021. PMID: 34066016 Free PMC article.
Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters.
Peletta A, Prompetchara E, Tharakhet K, Kaewpang P, Buranapraditkun S, Yostrerat N, Manopwisedjaroen S, Thitithanyanont A, Avaro J, Krupnik L, Neels A, Ruxrungtham K, Ketloy C, Borchard G. Peletta A, et al. Among authors: manopwisedjaroen s. Pharmaceutics. 2022 Jul 7;14(7):1427. doi: 10.3390/pharmaceutics14071427. Pharmaceutics. 2022. PMID: 35890321 Free PMC article.
29 results